Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse

British Journal of Cancer

Volumn 82, Issue 3, 2000, Pages 601-607

  Remes, K ^a   Norrback, K F ^a   Rosenquist, R ^a   Mehle, C ^a   Lindh, J ^a   Roos, G ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Clonality; Malignant lymphoma; Relapse; Telomerase activity; Telomere length; Tumour progression

Indexed keywords

ENZYME INHIBITOR; TELOMERASE;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE; TELOMERE; TUMOR GROWTH;

EID: 0033953479     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0970     Document Type: Article

References (32)

1. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW and Harley CB (1995) Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220: 194-200
2. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, Harley CB, Shay JW, Lichtsteiner S and Wright WE (1998) Extension or life-span by introduction of telomerase into normal human cells. Science 279: 349-352
3. Bryan TM and Reddel RR (1997) Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33: 767-773
4. Bryan TM, Englezou A, Dalla Pozza L, Dunham MA and Reddel RR (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumours and tumour-derived cell lines. Nat Med 3: 1271-1274
5. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greide CW and Villeponteau B (1995) The RNA component of human telomerase. Science 269: 1236-1241
6. Gravel S, Larriveé M, Labreeque P and Wellinger RJ (1998) Yeast Ku as a regulator of chromosomal DNA end structure. Science 280: 741-744
7. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E and Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84: 1361-1392
8. Hiyama E, Yokoyhama T, Hiyama K, Yamakido M, Santo T, Kodama T, Ichikawa T and Matsuura Y (1995a) Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int J Oncol 6: 13-16
9. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S and Yamakido M (1995b) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715
10. Holt SE, Norton JC, Wright WE and Shay JW (1996) Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci 18: 237-248
11. Härle-Bachor C and Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481
12. Jean-Louis M and Claude H (1998) G-quadruplex DNA: a target for drug design. Nat Med 4: 1366-1367
13. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
14. LaBranche H, Dupuis S, Ben-David Y, Bani M-R, Wellinger RJ and Chabot B (1998) Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Gen 19: 199-202
15. Levy MZ, Allsopp RC, Futcher AB, Greider CW and Harley CB (1992) Telomere end-replication problem and cell aging. J Mol Biol 225: 951-960
16. Mehle C, Mieczyslaw AP, Ljungberg B, Shay JW and Roos G (1996) Telomerase activity in human renal cell carcinoma. Onrogene 13: 161-166
17. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumour cells and during immortalization. Cell 90: 785-795
18. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE and Shay JW (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21: 115-118
19. Morin GB (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529
20. Norrback K-F and Roos G (1997) Telomeres and telomerase in normal and malignant haematopoietic cells. Eur J Cancer 33: 774-780
21. Norrback K-F, Dahlenborg K, Carlsson R and Roos G (1996) Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88: 222-229
22. Norrback K-F, Enblad G, Erlanson M, Sundström C and Roos G (1998) Telomerase activity in Hodgkin's disease. Blood 92: 567-573
23. Rosenquist R (1998) The immunoglobulin heavy chain gene as a clonal marker in lymphoma and leukemia. Umeå University medical dissertations, new series No 558-ISSN 0346-6612
24. Slagboom PE, Droog S and Boomsma DI (1994) Genetic determination of telomere size: a twin study of three age groups. Am J Hum Genet 55: 876-882
25. Strahl C and Blackburn EH (1996) Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16: 53-65
26. van Steensel B and de Lange T (1997) Control of telomere length by the human telomeric protein TRF I. Nature 385: 740-743
27. Vaziri H, Schächter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D and Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52: 661-667
28. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB and Lansdorp PM (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomcric DNA with age. Proc Natl Acad Sci USA 91: 9857-9860
29. Weng N-P, Levine BL, June CH and Hodes RJ (1995) Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 92: 11091-11094
30. Weng N-P, Granger L and Hodes RJ (1997) Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 94(20): 10827-10832
31. Wright WE, Shay JW and Piatyszek MA (1995) Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23: 3794-3795
32. Wynford-Thomas D (1997) Proliferative lifespan checkpoints: cell-type specificity and influence on tumour biology. Eur J Cancer 33: 716-726